146 related articles for article (PubMed ID: 5403606)
1. The neuromuscular blocking action of suxamethonium in the anaesthetised rat.
Ireson JD; Ford R; Loveday C
Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):283-6. PubMed ID: 5403606
[No Abstract] [Full Text] [Related]
2. The effects of succinylcholine, decamethonium, hexacarbacholine, gallamine and dimethyl tubocurarine on the twitch and tonic neuromuscular systems of the cat.
Katz RL; Eakins KE
J Pharmacol Exp Ther; 1966 Nov; 154(2):303-9. PubMed ID: 5922992
[No Abstract] [Full Text] [Related]
3. Interaction of verapamil with gallamine and pancuronium and reversal of combined neuromuscular blockade with neostigmine and edrophonium.
Wali FA
Eur J Anaesthesiol; 1986 Sep; 3(5):385-93. PubMed ID: 3780695
[TBL] [Abstract][Full Text] [Related]
4. Effect of carbon dioxide on gallamine and suxamethonium block in man. Preliminary communication.
Baraka A
Br J Anaesth; 1967 Oct; 39(10):786-8. PubMed ID: 6073465
[No Abstract] [Full Text] [Related]
5. The effect of dopamine and other catecholamines on neuromuscular transmission.
Blum K
Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):297-306. PubMed ID: 4326551
[No Abstract] [Full Text] [Related]
6. The interactions of neuromuscular blocking agents in man: the role of hexafluorenium.
Torda TA; Foldes FF; Bailey RJ; Klonymus DH; Kuwabara S
Anesthesiology; 1967; 28(6):1010-9. PubMed ID: 4383425
[No Abstract] [Full Text] [Related]
7. Nitroglycerin and the neuromuscular blockade produced by gallamine, succinylcholine, d-tubocurarine, and pancuronium.
Glisson SN; Sanchez MM; El-Etr AA; Lim RA
Anesth Analg; 1980 Feb; 59(2):117-22. PubMed ID: 6768318
[TBL] [Abstract][Full Text] [Related]
8. On the neuromuscular blocking action of succinylmonocholine in the rat.
Whittaker R
J Pharm Pharmacol; 1972 Apr; 24(4):340-1. PubMed ID: 4402850
[No Abstract] [Full Text] [Related]
9. Pharmacological studies of extraocular muscles.
Katz RL; Eakins KE
Invest Ophthalmol; 1967 Jun; 6(3):261-8. PubMed ID: 6026354
[No Abstract] [Full Text] [Related]
10. Effects of calcium on neuromuscular block by suxamethonium in dogs.
Badola RP; Chatterji S; Pandey K; Kumar S
Br J Anaesth; 1971 Nov; 43(11):1027-35. PubMed ID: 5131456
[No Abstract] [Full Text] [Related]
11. The potentiation of neuromuscular blocking agents by quinidine.
Miller RD; Way WL; Katzung BG
Anesthesiology; 1967; 28(6):1036-41. PubMed ID: 4383426
[No Abstract] [Full Text] [Related]
12. The effect of neuromuscular blocking agents on acetylcholine release.
Gergis SD; Dretchen KL; Sokoll MD; Long JP
Proc Soc Exp Biol Med; 1971 Nov; 138(2):693-5. PubMed ID: 4330238
[No Abstract] [Full Text] [Related]
13. The interaction of hexafluorenium with other neuromuscular blocking agents in man.
Foldes FF
Anaesthesist; 1966 Mar; 15(3):75-8. PubMed ID: 4383609
[No Abstract] [Full Text] [Related]
14. Effect of prior administration of suxamethonium on non-depolarising muscle relaxants in the dog.
Jones RS; Gleed RD
Res Vet Sci; 1984 Jan; 36(1):43-7. PubMed ID: 6709976
[TBL] [Abstract][Full Text] [Related]
15. Effects of anaesthetics and their interactions with neuromuscular blocking agents in cats.
Hughes R
Br J Anaesth; 1970 Oct; 42(10):826-33. PubMed ID: 4248885
[No Abstract] [Full Text] [Related]
16. Further observations on subacute denervation and mammalian motor nerve terminal function.
Bunn PA; Okamoto M; Riker WF
Neurology; 1973 Jan; 23(1):12-20. PubMed ID: 4347059
[No Abstract] [Full Text] [Related]
17. Classification of neuromuscular blocking agents in a new neuromuscular preparation of the chick in vitro.
van Riezen H
Eur J Pharmacol; 1968 Dec; 5(1):29-36. PubMed ID: 5718516
[No Abstract] [Full Text] [Related]
18. Interaction of diazepam with the muscle-relaxant drugs.
Feldman SA; Crawley BE
Br Med J; 1970 May; 2(5705):336-8. PubMed ID: 4317052
[TBL] [Abstract][Full Text] [Related]
19. [Influence of imipramine on curarism. II].
Bertolini A; Greggia A; Patrignani A; Zappata A
Boll Soc Ital Biol Sper; 1967 Jul; 43(13):800-1. PubMed ID: 4293402
[No Abstract] [Full Text] [Related]
20. Further studies on the neuromuscular effects of beta-diethylaminoethyl-diphenyl propylacetate hydrochloride (SKF-525-A).
Suarez-Kurtz G; Paulo LG; Fonteles MC
Arch Int Pharmacodyn Ther; 1969 Jan; 177(1):185-95. PubMed ID: 5353875
[No Abstract] [Full Text] [Related]
[Next] [New Search]
